Contraceptive Market Size, Share, Growth Report 2032

The global Contraceptive Market accrued earnings worth approximately 22.1 (USD Billion) in 2021 and is predicted to gain revenue of about 41.3 (USD Billion) by 2028, is set to record a CAGR of nearly 8.25% over the period from 2022 to 2028. The study provides assessment and analysis of the Contraceptive Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Request Free Sample

Contraceptive Market: Overview

Unmet needs of contraception in both emerging economies and industrially developed countries has steered demand for contraceptive methods in upcoming years. Furthermore, contraceptive use assists in reducing sexually transmitted diseases and unwanted pregnancies. Cost-affectivity of contraceptives and rise in funding of research activities related to producing of new kind of contraceptive with additional features is predicted to generate new growth avenues for contraceptive industry in ensuing years. Reportedly, contraceptive use among married women enhanced across globe from nearly 31% over 1960-1965 to about 58% in 1990. However, the surge was more rapid in emerging economies where use of contraceptive in married women  increased from 10% in 1960-1963 to about 54% in 1990. For the record, rise was drastic in east Asia & Latin America and little lesser in some other parts of Asia and North Africa.

Contraceptive Market: Growth Dynamics

Expansion of contraceptive market over forecast timeline is subject to growing need for reducing risk of sexually transmitted disorders and health related problems. In addition to this, increase in number of gynecologists preferring contraception device for birth control will soar progression of contraceptive market. Apparently, increase in awareness pertaining to new kinds of contraceptives along with surge in utilization of oral pills will result in massive demand for contraceptive equipment. Furthermore, technological breakthroughs & acceptance of new contraception tools will play a pivotal part in growth of contraceptive industry. Nonetheless, hazardous effects of contraceptive medicines can pose a challenge to growth of contraceptive market. Additionally, injectable contraceptive administration has resulted in abdominal bleeding, depression, and alopecia. Apart from this, rise in cases of infertility caused due to intake of contraceptive pills can also hamper business landscape.

Furthermore, oral contraceptives protects individual against fallopian tube infection, ovarian cysts, and anemia risk. Moreover, it helps in reducing menstrual pain as well as pain occurring during ovulation. Male contraceptives such as condoms offer protection against viral and bacterial infection and delays sperm allergy & premature ejaculation along with helping in increasing penile erection. Contraceptives such as spermicides offers protection against gonorrhea and chlamydia as well as against sexualy transmitted disease such as syphilis. All these aforementioned aspects will boost growth in contraceptive market size.

Request Free Sample

Contraceptive Market: Regional Landscape

North America To Contribute Majorly Towards Regional Market Size By 2028

Growth of regional market over forecasting timeline is due to growing awareness about birth control pills in countries such as the U.S. Reportedly, cost-efficiency of contraception in countries such as the U.S. will drive regional market trends. Huge acceptance of new products in North America will embellish expansion of contraceptive market in North America. Rise in launching of awareness schemes related to use of contraceptive & high focus on family planning programs by U.S. government will proliferate size of contraceptive market in sub-continent.

Breakthroughs Witnessed in Contraceptive Market

• In December 2020, Irish Government declared plan on launching free contraception to women ranging from 17 year to 25 years.
• In July 2018, the U.S. administration announced extension of exemption facility to exclude Affordable Care Act law that mandates staff to encompass birth control coverage in health insurance policy.

Contraceptive Market: Competitive Insights

Key players have majorly leveraged business space and will continue to do so in coming years. They are The Female Health Company, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bayer Healthcare Pharmaceuticals LLC, Pfizer, Inc., Piramal Healthcare Limited, Reckitt Benckiser Group PLC, Lupin Pharmaceuticals, Inc., Cipla Limited, Novartis AG, and Glenmark Pharmaceuticals Limited.

Report Scope:

The global Contraceptive Market is segmented as follows:

By Product

• Oral Contraceptive Pills
• Topical Contraceptive Pills
• Injectable Contraceptive Pills
• Diaphragms
• Vaginal Rings
• Condoms
• Contraceptive Sponges,
• Subdermal Implants
• Intra-Uterine Devices

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa